Navigation Links
BioCryst Updates Peramivir Clinical Development Plan
Date:1/23/2008

d life-threatening influenza. In the United States, intravenous peramivir injection has received Fast Track designation from the Food and Drug Administration (FDA).

About Influenza

The influenza virus causes an acute viral disease of the respiratory tract. Unlike the common cold and some other respiratory infections, seasonal influenza can cause severe illness, resulting in life-threatening complications. According to the Centers for Disease Control and Prevention, every year in the United States as many as 750,000 people are hospitalized due to influenza or its complications, and of this number, an estimated 40,000 people die each year. Most at risk are young children, the elderly, and people with seriously compromised immune systems.

Avian influenza A viruses of H5N1 subtype are circulating among birds worldwide. The virus is considered extremely contagious in fowl. It is believed that all species of birds are susceptible to avian influenza, but domestic poultry, including chickens and turkeys, are among the more susceptible to the highly pathogenic strain. According to the World Health Organization, as of December 2007 at least 331 people have been infected with H5N1 avian influenza, of which at least 200 have died. Almost all of these infections are believed to have resulted from contact with infected poultry.

About BioCryst

BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The Company is advancing multiple internal programs toward potential commercialization including forodesine HCl in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life- threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization of BCX-4208, and is collaborating with Mundipharma for t
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
2. BioCryst Provides Forodesine HCl Update
3. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
4. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
5. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
6. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
7. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
8. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Medical Systems (NYSE: VAR ) today is ... the third quarter of fiscal year 2014.  Net earnings ... due to an approximately $8 million impairment charge related ... Augmenix, a privately-held company developing minimally invasive hydrogels for ... third quarter of fiscal year 2014, up 3 percent ...
(Date:7/23/2014)... 23, 2014 Research and Markets  has ... Market by Product, End-user & by Lead Type - ... http://photos.prnewswire.com/prnh/20130307/600769 ... three major segments, namely, holter monitor, resting, and stress ... at $3,683 million in 2013 and is poised to ...
(Date:7/23/2014)... , July 23, 2014  RT Oncology Services Corporation ... to join its board of directors. Mr. Mundie is ... where he works on strategic projects within the company ... Microsoft,s chief research and strategy officer. ... of RainTree, said, "Craig is a visionary technology executive. ...
Breaking Medicine Technology:Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 3Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 4Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 5Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 6Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 7Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 8Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 9Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 10Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 2Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 3Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3
... SGP ), a leader in advancing the ... infection, announced today that final,results of the IDEAL ... studies,with PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP),combination ... for the,Study of the Liver (EASL) 43rd annual ...
... Kosan Biosciences,Incorporated (Nasdaq: KOSN ) presented ... showing potent in vitro and in vivo,activity as ... further,elucidating the NEI anticancer mechanism of action correlating ... selectively in cancer cells,compared to normal cells. Data ...
Cached Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 7Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 8Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 9Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR 2Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR 3Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR 4
(Date:7/23/2014)... The National Institute of Biomedical Imaging and Bioengineering ... Symposium on July 30, 2014 on the NIH campus. ... investigators covering a wide breadth of NIBIB-funded research. ... Cohen, Harvard, Engineering Microbial Rhodopsins as Optical Voltage Sensor, ... Fluorescently Labeled Probes for Nerve Imaging ...
(Date:7/23/2014)... Ft. Lauderdale, FL (PRWEB) July 23, 2014 ... and the largest online retailer of nutritional supplements, has ... Supplement Awards. BPI SPORTS , the fastest growing ... the following categories: , Brand of the Year, Best ... of the Year, Protein Powder of the year - ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Olympic gold ... in Roanoke, Virginia on Friday, July 18. Hedrick visited ... Sports Subway Commonwealth Games, an Olympic-style event celebrating its ... first year as a premier sponsor of the Commonwealth ... people of all ages and all activity levels. , ...
(Date:7/23/2014)... In a massive effort to catalog the ... at Dana-Farber Cancer Institute, have identified four subtypes ... molecular abnormalities. They say the new classification promises ... for the third-leading cancer killer worldwide. , In ... The Cancer Genome Atlas Research Network said they ...
(Date:7/23/2014)... getting enough sleep may increase the likelihood of forming ... Science , a journal of the Association for Psychological ... Steven J. Frenda of the University of California, Irvine ... crime being committed and then read false information about ... false details in the photos than were those who ...
Breaking Medicine News(10 mins):Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 3Health News:US Olympian Chad Hedrick Visits Foot Levelers 2Health News:New view of stomach cancer could hasten better therapies 2Health News:New view of stomach cancer could hasten better therapies 3Health News:Sleep deprivation may increase susceptibility to false memories 2
... recent survey conducted by Decision Analyst (an independent research ... Lomb revealed that 4 out of 10 consumers incorrectly ... lenses. A total of 3,287 individuals with astigmatism were ... lenses and nearly half of those who have worn ...
... than ever that having health insurance is essential for ... enough to prevent avoidable illness, worse health outcomes, and ... of Medicine. Moreover, new research suggests that when local ... insurance are more likely to have difficulty obtaining needed ...
... 24 WellPoint, Inc. (NYSE: WLP ) ... the meeting,WellPoint,s executive leadership team reviewed the company,s performance ... detailed company,guidance for 2009. , ... we expect,growth of 1 percent to 3 percent over ...
... popular supplements, according to survey - WASHINGTON, Feb. 24 ... the usual staples of cereal, coffee filters, and bottles of ... who take vitamins and other supplements every year are keeping ... 2008 CRN Consumer Survey on Dietary Supplements , 52 percent ...
... To Set Standards For Rapidly Growing Profession; Protect ... graduated the nation,s first credentialed private healthcare advocates. ... CEO Joanna Smith, LCSW, MPH. "Our first graduates ... true pioneers," says Smith. "They represent the professional ...
... Teva Pharmaceuticals USA, the leading generic pharmaceutical company, ... videos as part of the "Year of Affordable ... at www.yearofaffordablehealth.com/gallery ) is meant to illustrate ... everyday Americans since the passage of Waxman-Hatch 25 ...
Cached Medicine News:Health News:Bausch & Lomb Survey Shows People with Astigmatism Unaware of Contact Lens Options 2Health News:Health insurance essential for health and well-being 2Health News:Health insurance essential for health and well-being 3Health News:WellPoint Highlights Operational Accomplishments and Details 2009 Guidance at Annual Investor Meeting 2Health News:WellPoint Highlights Operational Accomplishments and Details 2009 Guidance at Annual Investor Meeting 3Health News:WellPoint Highlights Operational Accomplishments and Details 2009 Guidance at Annual Investor Meeting 4Health News:WellPoint Highlights Operational Accomplishments and Details 2009 Guidance at Annual Investor Meeting 5Health News:WellPoint Highlights Operational Accomplishments and Details 2009 Guidance at Annual Investor Meeting 6Health News:WellPoint Highlights Operational Accomplishments and Details 2009 Guidance at Annual Investor Meeting 7Health News:Consumers and Healthcare Professionals Agree - Kitchen Cabinet is Home for My Supplements 2Health News:Consumers and Healthcare Professionals Agree - Kitchen Cabinet is Home for My Supplements 3Health News:Healthcare Liaison Graduates Nation's First Credentialed Private Healthcare Advocates - Graduates are Pioneers in Emerging Profession 2
... These color vision tests have been designed ... the type and estimating the grade of ... measure Red, Green, Blue, Yellow. They provide ... deficiencies. Screening is accomplished using the initial ...
... The Richmond Products version of the Farnsworth ... containers which make scoring easy and reduces the ... patients disc sequence intact. ,The Farnsworth 100 Hue ... four clear Acrylic boxes, a tray, a durable ...
Gas powered, single use, reloadable, laparoscopic 15 mm linear cutting stapler for resection, transection and anastomosis with titanium staples....
... Acrylic is the newest technology available in ... lens combines exceptional material and design properties ... , Biostability , Unique foldable hydrophobic acrylic ... to be biostable , High index ...
Medicine Products: